Coronavirus Treatment Keeps Recovery Intact

Daily Market Comment

July 10, 2020

Coronavirus Treatment Keeps Recovery Intact

U.S. stocks opened the session flat before moving higher on Gilead’s Remdesivir drug showing improved clinical recovery while reducing the risk of death in Covid-19 patients. That good news kept a lid on potential losses stemming from the Producer Price Index (PPI) surprising economists with a drop of 0.2% in June. Economists were forecasting for a climb of 0.4% but rising costs for energy goods were a drag last month. The news of Remdesivir’s success led to a rotation out of technology stocks and into Airlines and Cruise lines stocks, led by United Continental (+8.3%) and Carnival Corp (+10.8%). The advance was led by Financials (XLF), Energy (XLE) and Utilities (XLU), while Health Care (XLV), Technology (XLK), and Real Estate (XLRE) were all lower. The DJIA finished the week higher after gaining 369.21 points (+1.44%) today, to settle at 26075.30 while the S&P 500 climbed 32.99 points (+1.05%) and ended the session at 3185.04. The NASDAQ continues its red-hot streak where it jumped 69.69 points (+0.66%) to settle at 10617.44. The NASDAQ has now closed at new all-time highs in six of the last seven sessions.

Breadth was bullish with advancing issues beating declining issues by 3:1 on the NYSE and 769 units on the NASDAQ. Advancing volume was 82% on the NYSE and 62% on the NASDAQ. VIX moved back down 1.97points (-6.73%) and finished at 27.29. Crude oil prices improved by 1.00 points (+2.52%) and the September contract closed at $40.62 a barrel. Gold inched lower by 2.00 (-0.11%) to $1801.80 an ounce.

As we mentioned earlier this week, the market can seemingly digest news of rising Covid-19 cases so long as the mortality rate remains low and progress is being made on a breakthrough vaccine. Momentum, as measured by the 14-day RSI, ticked up while the NYSE A/D line, a leading indicator of net advances, closed nearly even after tumbling during the middle part of the week. Next week, a range of economic factors and important earnings reports are on the slate. Market participants will gauge closely if a recovery is in full swing or if the pandemic shifts into reverse.

Earnings releases to watch for on Monday includes: PepsiCo (PEP)

By Richard Cuvilly

Login to MarketEdge

Don't have an account? Sign up now.

Market Indicators

Market Posture Cyclical Trend Index
As of: 05/29/2020
As of: 06/26/2020
Looking for the S&P Oscillator?
The proprietary S&P Short-Range Oscillator is a number that is calculated each market day and helps professionals measure the pulse of the market.
Published for decades only as part of an S&P Trendline/Daily Action Stock Charts subscription, the proprietary S&P Short-Range Oscillator is now available exclusively by special arrangement through Computrade/MarketEdge®
Click to Sign Up

Second Opinion Performance

Second Opinion Status


Current Opinions
As of: 07/10/2020


Long Accuracy
As of: 07/10/2020


Avoid Accuracy
As of: 07/10/2020
Click For More Details

Market Recap - 07/10/2020

Index Close Day Change Day % Change YTD % Change
NASDAQ COMPOSITE 10617.44 69.69 0.66% 18.33%
DJ UTILITIES 791.35 17.12 2.21% -9.98%
DJ TRANSPORT 9312.48 172.05 1.88% -14.57%
DJ INDUSTRIALS 26075.3 369.21 1.44% -8.63%
NYSE COMPOSITE 12075.58 146.95 1.23% -13.2%
S & P 100 INDEX 1481.96 15.92 1.09% 2.75%
RUSSELL 2000 1422.68 23.76 1.7% -14.05%
S&P 500 3185.04 32.99 1.05% -1.41%
CBOE MKT VOLATILITY 27.29 -1.97 -6.73% 98.04%
AMEX COMPOSITE 1977.91 7.13 0.36% -22.51%
Dr MarketEdge Talks Stocks

Tuesday, July 7th 2020, 12:00 am



Get Started

Second Opinion on over 3400 stocks, nightly updates for stocks on your watchlist, dozens of tools to find the right stock at the right time, as well as real human support available by chat, email, and phone.

About MarketEdge

MarketEdge is a unique suite of investment tools developed by Computrade Systems, Inc. The purpose of our service is to provide quality, independent research in a manner that is both easily understandable and immediately actionable for individual investors as well as professional money managers. MarketEdge features Second Opinion®, a comprehensive computer-generated technical evaluation of more than 3,400 stocks, along with fundamental research from Standard & Poor's. MarketEdge will generate daily investment ideas for every type of trading strategy thereby enabling one to trade and invest with a consistent, disciplined approach in all market environments.

Logging in...